ArticleJournal of magnetic resonance imaging : JMRI2026
AI-Powered Gradient Echo Plural Contrast Imaging (AI-GEPCI)-A Comprehensive Neurological Protocol From a Single MRI Scan.
Article in Journal of magnetic resonance imaging : JMRI, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Update of
Authors and funding
9 authors.
Funding
Abstract
backgroundMRI is essential for diagnosing and monitoring neurological diseases. Conventional protocols require multiple sequences to obtain complementary contrasts, increasing scan time, cost, and tolerability. Generating multiple contrasts from a single acquisition may streamline workflow while maintaining clinical utility. PURPOSE: To train attention-based convolutional neural networks (ACNNs) to generate clinical-quality Fluid-Attenuated-Inversion-Recovery (FLAIR), Magnetization-Prepared-Rapid-Gradient-Echo (MPRAGE), R2* maps, and derived contrasts from a single Gradient Echo Plural Contrast Imaging (GEPCI) acquisition. STUDY TYPE: Retrospective. POPULATION: 43 MRI scans from individuals with multiple sclerosis (25/18 F/M, 49 ± 11 years-of-age). FIELD STRENGTH/SEQUENCE: 3 T MRI, 3D GEPCI, MPRAGE, and FLAIR. ASSESSMENT: Technical quality of AI-generated contrasts was evaluated against directly acquired MRI using structural similarity index (SSIM). Clinical image quality was assessed by physicians. Lesion volumes and counts were obtained using automated segmentation. STATISTICAL TESTS: One-sample one-sided Wilcoxon signed-rank test was used to establish the clinical quality of images. Agreement between native- and AI-derived lesion volume and lesion count measurements was assessed using intraclass correlation coefficients (ICC). Quantitative accuracy for R2* maps was evaluated using normalized root-mean-square error (NRMSE).
resultsAI-generated FLAIR and MPRAGE achieved mean SSIM values of 0.923 ± 0.028 and 0.935 ± 0.022, respectively. Generated R2* maps achieved a mean SSIM of 0.996 ± 0.006 and NRMSE of 0.031 ± 0.020. Physicians-assigned mean clinical quality ratings of 4.2 for GEPCI-FLAIR and 4.5 for GEPCI-MPRAGE exceeded the 4.0 clinical standard on a 1-to-5 scale. Lesion volume and count comparisons from automated segmentation showed strong agreement between AI-generated and ground-truth measurements: R DATA
conclusionAI-GEPCI generated multiple clinically relevant MRI contrasts from a single GEPCI acquisition with high similarity to corresponding acquired images, supporting high-quality, intrinsically co-registered multi-contrast brain evaluation. EVIDENCE LEVEL: 2. TECHNICAL EFFICACY: Stage 1.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.